Fluorescein lisicol

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameFluorescein lisicol
Drug Alias NameCholyl-lysyl-fluoresceinNRL-972NRL972
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiagnostic imaging enhancers
TargetsBile acids
Therapy Area/IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseHepatitis, Viral, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesRomania +[5] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNorgine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorgine
Active IndicationsN/A
Inactive IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseHepatitis, Viral, Human

Other Information

ATC CodeN/A
Related LinksN/A